• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹部盆腔癌症手术后,使用低分子肝素(LMWH)进行延长的血栓预防。

Extended thromboprophylaxis with low-molecular weight heparin (LMWH) following abdominopelvic cancer surgery.

机构信息

Ottawa Hospital Research Institute, Ottawa Hospital - General Campus, 501 Smyth Road, Box 201a, Ottawa, Ontario, K1H 8L6, Canada.

University of Manitoba, CancerCare Manitoba, Health Sciences Center, 810 Sherbrooke St., Rs406, Winnipeg, Manitoba, R3A-1R9, Canada.

出版信息

Am J Surg. 2019 Sep;218(3):537-550. doi: 10.1016/j.amjsurg.2018.11.046. Epub 2018 Dec 16.

DOI:10.1016/j.amjsurg.2018.11.046
PMID:30595331
Abstract

BACKGROUND

Venous thromboembolism (VTE) includes deep vein thrombosis (DVT) and pulmonary embolism (PE). Certain abdominopelvic cancer surgeries are associated with a six to 14-fold increased risk of DVT versus surgeries for benign disease, and extended thromboprophylaxis using perioperative LMWHs may further reduce VTE rates over standard duration administration. This review assesses the value of extended low molecular weight heparin (LMWH) thromboprophylaxis as a recommended strategy after abdominopelvic cancer surgery.

DATA SOURCES

Six eligible randomized controlled trials (RCTs), seven meta-analyses (MAs), and five non-randomized cohort studies were identified evaluating extended versus standard thromboprophylaxis following abdominopelvic cancer surgery.

FINDINGS AND CONCLUSIONS

Available evidence showed significantly reduced rates of VTE for extended versus standard LMWH thromboprophylaxis following abdominopelvic cancer surgery, with some studies showing trends toward reduced rates of symptomatic VTE events. Many of these studies showed significantly reduced rates of proximal DVT and some showed trends toward reduced PE, suggesting potentially important clinical benefits.

摘要

背景

静脉血栓栓塞症(VTE)包括深静脉血栓形成(DVT)和肺栓塞(PE)。某些腹盆腔癌症手术与良性疾病手术相比,DVT 的风险增加 6 至 14 倍,使用围手术期低分子肝素(LMWH)进行延长血栓预防可能会进一步降低标准持续给药的 VTE 发生率。本综述评估了延长低分子肝素(LMWH)血栓预防在腹盆腔癌症手术后作为推荐策略的价值。

资料来源

共确定了 6 项合格的随机对照试验(RCT)、7 项荟萃分析(MA)和 5 项非随机队列研究,评估了腹盆腔癌症手术后延长与标准血栓预防的效果。

结果和结论

可用证据表明,与标准 LMWH 血栓预防相比,腹盆腔癌症手术后延长 LMWH 血栓预防可显著降低 VTE 发生率,一些研究显示症状性 VTE 事件发生率有降低趋势。这些研究中有许多显示近端 DVT 发生率显著降低,有些研究显示 PE 发生率有降低趋势,这表明可能具有重要的临床获益。

相似文献

1
Extended thromboprophylaxis with low-molecular weight heparin (LMWH) following abdominopelvic cancer surgery.腹部盆腔癌症手术后,使用低分子肝素(LMWH)进行延长的血栓预防。
Am J Surg. 2019 Sep;218(3):537-550. doi: 10.1016/j.amjsurg.2018.11.046. Epub 2018 Dec 16.
2
Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.低分子量肝素用于腹部或盆腔手术的延长血栓预防
Cochrane Database Syst Rev. 2019 Aug 26;8(8):CD004318. doi: 10.1002/14651858.CD004318.pub5.
3
Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.低分子量肝素用于腹部或盆腔手术的长期血栓预防。
Cochrane Database Syst Rev. 2019 Mar 27;3(3):CD004318. doi: 10.1002/14651858.CD004318.pub4.
4
Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.低分子量肝素用于腹部或盆腔手术的长期血栓预防。
Cochrane Database Syst Rev. 2018 Nov 27;11(11):CD004318. doi: 10.1002/14651858.CD004318.pub3.
5
Role of Extended Thromboprophylaxis After Abdominal and Pelvic Surgery in Cancer Patients: A Systematic Review and Meta-Analysis.腹部和盆腔手术后延长血栓预防在癌症患者中的作用:一项系统评价和荟萃分析。
Ann Surg Oncol. 2016 May;23(5):1422-30. doi: 10.1245/s10434-016-5127-1. Epub 2016 Feb 17.
6
Extended thromboprophylaxis following major abdominal/pelvic cancer-related surgery: A systematic review and meta-analysis of the literature.大腹部/骨盆癌症相关手术后的延长血栓预防:文献的系统评价和荟萃分析。
Thromb Res. 2021 Aug;204:114-122. doi: 10.1016/j.thromres.2021.06.010. Epub 2021 Jun 19.
7
Direct oral anticoagulants (DOACs) versus low-molecular-weight heparin (LMWH) for extended thromboprophylaxis following major abdominal/pelvic cancer-related surgery: a systematic review and meta-analysis.直接口服抗凝剂(DOACs)与低分子量肝素(LMWH)用于腹部/盆腔重大癌症相关手术后的延长血栓预防:一项系统评价和荟萃分析。
Surg Endosc. 2024 Mar;38(3):1131-1138. doi: 10.1007/s00464-023-10649-y. Epub 2024 Jan 24.
8
Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.低分子量肝素用于腹部或盆腔手术的长期血栓预防
Cochrane Database Syst Rev. 2009 Jan 21(1):CD004318. doi: 10.1002/14651858.CD004318.pub2.
9
Extended versus conventional thromboprophylaxis after major abdominal and pelvic surgery: Systematic review and meta-analysis of randomized clinical trials.大型腹部和骨盆手术后的延长与常规血栓预防:随机临床试验的系统评价和荟萃分析。
Surgery. 2018 Dec;164(6):1234-1240. doi: 10.1016/j.surg.2018.05.028. Epub 2018 Sep 3.
10
Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.高危外科和内科患者出院后使用低分子量肝素进行延长血栓预防:一项综述
Clin Ther. 2009 Jun;31(6):1129-41. doi: 10.1016/j.clinthera.2009.06.002.

引用本文的文献

1
Colorectal Cancer: Therapeutic Approaches and Their Complications.结直肠癌:治疗方法及其并发症
Biomedicines. 2025 Jul 5;13(7):1646. doi: 10.3390/biomedicines13071646.
2
Circulating eosinophil cell-free DNA as a noninvasive biomarker for perforated appendicitis in pediatric patients-a proof-of-concept study.循环嗜酸性粒细胞游离DNA作为小儿穿孔性阑尾炎的无创生物标志物——一项概念验证研究
Sci Rep. 2025 Apr 22;15(1):13980. doi: 10.1038/s41598-025-98615-7.
3
The Role of Extended Thromboprophylaxis With Low-Molecular-Weight Heparin Following Abdominopelvic Surgery for Cancer.
低分子量肝素延长血栓预防在癌症患者腹盆腔手术后的作用
Clin J Oncol Nurs. 2025 Jan 17;29(1):19-24. doi: 10.1188/25.CJON.19-24.
4
Gynecological Cancer and Venous Thromboembolism: A Narrative Review to Increase Awareness and Improve Risk Assessment and Prevention.妇科癌症与静脉血栓栓塞症:一篇旨在提高认识、改善风险评估与预防的叙述性综述
Cancers (Basel). 2024 May 3;16(9):1769. doi: 10.3390/cancers16091769.
5
Risk of Bleeding and Venous Thromboembolism after Colorectal Cancer Surgery in Patients with and without Type 2 Diabetes: A Danish Cohort Study.2型糖尿病患者与非2型糖尿病患者结直肠癌手术后出血和静脉血栓栓塞的风险:一项丹麦队列研究
TH Open. 2024 Mar 26;8(1):e146-e154. doi: 10.1055/a-2275-9590. eCollection 2024 Jan.
6
Timing of symptomatic venous thromboembolism after surgery: meta-analysis.手术后症状性静脉血栓栓塞的时间:荟萃分析。
Br J Surg. 2023 Apr 12;110(5):553-561. doi: 10.1093/bjs/znad035.
7
Perioperative Prevention of Venous Thromboembolism in Abdominal Surgery Patients Based on the Caprini or the Padua Risk Score-A Single Centre Prospective Observational Study.基于Caprini或Padua风险评分的腹部手术患者围手术期静脉血栓栓塞的预防——一项单中心前瞻性观察研究
Life (Basel). 2022 Nov 11;12(11):1843. doi: 10.3390/life12111843.
8
Perioperative coagulofibrinolytic responses in colorectal surgery patients without chemical thromboprophylaxis: a retrospective observational study.结直肠手术患者无化学性血栓预防措施的围手术期凝血纤溶反应:一项回顾性观察研究。
Surg Today. 2022 Jun;52(6):904-913. doi: 10.1007/s00595-021-02393-4. Epub 2021 Oct 25.
9
Systematic reviews of observational studies of Risk of Thrombosis and Bleeding in General and Gynecologic Surgery (ROTBIGGS): introduction and methodology.普通外科和妇科手术中血栓形成与出血风险的观察性研究的系统评价(ROTBIGGS):引言与方法
Syst Rev. 2021 Oct 8;10(1):264. doi: 10.1186/s13643-021-01814-2.
10
Extended-duration thromboprophylaxis after ventral hernia repair: a risk model to predict venous thrombotic events after hospital discharge.腹外疝修补术后延长时间的血栓预防:预测出院后静脉血栓栓塞事件的风险模型。
Hernia. 2022 Jun;26(3):919-926. doi: 10.1007/s10029-021-02481-x. Epub 2021 Aug 15.